Phillips-Medisize corp. honored as supplier to MDEA finalist ivWatch

Phillips-Medisize congratulates ivWatch, LLC on their recent recognition as a finalist in Medical Design Excellence Awards (MDEA). ivWatch LLC is a nominee for the Model 400 device in the Nonsurgical Hospital Supplies and Equipment category. Winners will be announced on June 13, in New York, during a ceremony at MD&M East.

The ivWatch Model 400 is a device that continuously monitors a patient’s peripheral IV for the early detection of infiltrations – when medication or fluid leaks outside the vein into the surrounding tissue. Intravenous therapy is a routine part of treatment for nearly 80% of patients in the U.S., and more than 20% of these IVs may fail because of infiltration. Because every IV failure risks both a serious drug delivery error and tissue damage, earlier detection of those failures is the new and next step for minimizing this potential for patient harm.

“We have partnered with ivWatch since 2011 on development and production, so it is a true privilege to be recognized as a supplier for their program. They are a great example of a company that utilized our full capabilities, from design to manufacturing,” comments Matt Jennings, Chairman and CEO, Phillips-Medisize.

“Phillips-Medisize has been a valued-partner in getting the ivWatch Model 400 to market. We have leveraged their design and manufacturing expertise to solve a significant medical issue,” says Gary Warren, ivWatch President & CEO. “It is a pleasure to be able to recognize the team at Phillips-Medisize as one of our honored suppliers for the MDEA Competition.”

The MDEA are the medtech industry’s premier design competition committed to recognizing significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. The awards program celebrates the accomplishments of the medical device manufacturers, their suppliers, and the many people behind the scenes—engineers, scientists, designers, and clinicians—who are responsible for the cutting-edge products that are saving lives; improving patient healthcare; and transforming medtech—one innovation at a time.

The 2017 MDEA Juror Panel selected 45 exceptional finalists in nine medical technology product categories. Products were judged based on design and engineering innovation; function and user-related innovation; patient benefits; business benefits; and overall benefit to the healthcare system. Unlike other design competitions that are merely styling contests, the MDEA jury is comprised of a balance of practicing doctors, nurses, and technicians alongside industrial designers, engineers, manufacturers, and human factors experts.